Member Info for AquaeSulis01

Boy, whatever it is, ITM seems to also be mirroring the Ceres Power pattern so suspect; maybe bearing in mind the low volumes just MM games?
https://www.griproom.com/fun/10-signs-your-stock-is-being-manipulated
6. Your stock is red all the time for seemingly no reason.
I call this the Triple Red Attack. These drops tend to be smaller. Usually between -0.05% and -1.5%.
They sell enough shares to keep it red during the pre-market. During regular hours they’ll nuke it as much as 2-3%. Before the day is up, they’ll often let the stock recover a bit. This is so they can paint it red after hours. It also allows them more room for it to drop tomorrow.
It forms this type of pattern.
triple red attack.jpg
This was taken from a six-month chart of $GILD. But if you look at most one-day, or one-week charts, they share a similar pattern.
You see, manipulators can only smash a stock so hard. They can’t nuke it 5% a day indefinitely. If they bash it too hard, then they’ll let it recover to reestablish positive sentiment. Then the Triple Red Attack starts over again.
Wall Street’s goal is to destroy a stock just enough to frustrate retail investors, but not enough to attract the attention of regulators, or serious value investors

Blimey, never known someone as unpopular MIK :)

On the current Opti share price not reflecting the current and potential value of the company, you, SOH and I are in complete agreement

..and finally, finally, it's worth bearing in mind that much like skin's partner Croda, Opti's US Business partner prior to investing millions in scaling up the manufacture of sweetbiotix, will have first satisfied themselves that the demand and commitment was there from major business customers i.e. sweetbiotix will undoubtedly have been successfully incorporated in different companies' products and taste tested first.

Hi Skid,
There was no intent to directly associate Opti with Nestle; but I am a big believer in Sweebiotix as a product that once launched commercially by the major unnamed US partner, will lead to that partner creating deals with the likes of Nestle, Kelloggs etc rather than end businesses that no-one has heard of.

The Nestle link was a recent article about the issues that a number of major food producers are facing in creating products that contain a lot less "red label" ingredients like sugar, in a post Covid world where there has never been a greater focus on health at a time when Obesity and Diabetes has shot up globally, so why wouldn't all the top Food companies be interested in a "green label" sugar substitute like sweetbiotix?

Finally, from the RNS extract "Enhanced royalty payments will be made to OptiBiotix on sale of SweetBiotix® products by the Company to 11 application/innovation partners with whom OptiBiotix has been in long term discussions regarding exploring the use of SweetBiotix® products in dairy, cereal and beverage applications" who is to say that one of those long term discussion wasn't with the likes of Nestle after all our ex Director, Christina Mary Wood, as the owner and CEO of Confoco, a supplier of high quality food ingredients worldwide, grew the business from £1m to £11m sales by obtaining strategic supplier status with multiple global corporates including Nestlé, Danone, and Heinz, so certainly had the contacts?
https://www.proactiveinvestors.co.uk/LON:OPTI/OptiBiotix-Health-PLC/rns/251817

Skid, Nestle put a lot of sugar in their products but they don't refine it themselves. Besides, it is Opti's major Business partner who will be licensed to manufacture and supply sweetbiotix; from the RNS
"OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high

cholesterol and diabetes announces that it has entered into an agreement with a US company ("the US Company") for the purpose of large scale manufacture and commercialisation of a number of SweetBiotix® products.
The agreement grants the US Company an exclusive worldwide license in return for it bearing the costs relating to product manufacturing, marketing, and all future costs relating to the commercialisation of a number of SweetBiotix® products.



OptiBiotix will receive a modest six-figure payment from the Company on signing the agreement and at 12 monthly intervals until product launch. Additional similar payments will be due on product launch plus royalties on all future product sales. Enhanced royalty payments will be made to OptiBiotix on sale of SweetBiotix® products by the Company to 11 application/innovation partners with whom OptiBiotix has been in long term discussions regarding exploring the use of SweetBiotix® products in dairy, cereal and beverage applications"

Not just shareholders looking forward to the sweetbiotix launch
https://www.dailymail.co.uk/news/article-9638529/Nestl-says-60-brands-unhealthy-despite-slashing-salt-sugar-levels.html
Nestlé says 60% of its brands are unhealthy despite slashing salt and sugar levels

jack irrespective of what a broker's note said, good or bad, the thing that attracted my attention is the fact that the Company has two diamond (truth) drills going on at the same time; and if either results in a find that moves the site from the Speculation to discovery phase the share price will leap (see life cycle related to share price movement link). It's a gamble but one that will be handsomely rewarded if it pays off.

https://www.visualcapitalist.com/visualizing-the-life-cycle-of-a-mineral-discovery/

Wake me up once diamond (truth) drilling commences/re-commences on any of the projects, this needs to move from pre discovery to discovery to make a difference to the share price

Just hold onto these cheap shares as there are only so many to go around and the pension funds are coming
https://www.express.co.uk/news/nature/1444323/green-britain-pension-funds-emissions-cut

Green Britain: Pension funds can drive the fight to cut emissions
BLACKADDER creator Richard Curtis and former Governor of the Bank of England Mark Carney joined forces yesterday to urge the world's £33trillion pensions industry to save the planet.
By JOHN INGHAM, ENVIRONMENT EDITOR
PUBLISHED: 10:07, Wed, Jun 2, 2021 | UPDATED: 10:07, Wed, Jun 2, 2021
2Comment sectionShare on FacebookShare on TwitterShare on LinkedInShare on PinterestCopy link
Green Britain: John Ingham and Dale Vince discuss campaign
Sign up for FREE for latest news plus tips to save money and the environment
Enter your email address here
SUBSCRIBE
When you subscribe we will use the information you provide to send you these newsletters. Sometimes they'll include recommendations for other related newsletters or services we offer. Our Privacy Notice explains more about how we use your data, and your rights. You can unsubscribe at any time.

They hosted the world’s first Net Zero Pension Summit and have already won the backing of funds worth more than £400billion. They want pension managers to invest in sustainable businesses and to cut emissions to zero or offset them by, say, planting trees, by 2050. It means many funds would have to remove their investments from fossil fuels, for example, and switch them to green energy.

belgrano, the importance of marketing cannot be stressed enough, it is not enough to have good products without the appropriate marketing as Opti have proven. That said, in Stuart, who formally worked as a Sales and Marketing Director at Smith and Nephew, Skin have an expert in the field so I have a lot of confidence in his target figures being achieved.

belgrano "and leave with one small snippet "Thousands of people on the waiting list"...thats the difference." I presume you mean the register of interest without commitment, in which case I was not aware the company had released figures for the interest to-date?

You are missing nothing Littlebobby this is a cracking investment at the current sp. Whilst the results due out next month wont be a lot different from the unaudited figures published in Feb, it will be interesting to see what SOH decides to put into the Outlook re future sales of slimbiome and LPLDL and then when the sweetbiotix launch is announced, which could be anytime, things will get really exciting

Marx, let's take your point D which is inaccurate, a simple google search will reveal the published paper by Prof Cath that underpins the whole science behind the gut/skin axis and how understanding the pathways will enable microbiome modulation to take place with different mixes of good gut probiotics to be engineered to tackle specific imbalances that result in over production of skin cells etc
https://pubmed.ncbi.nlm.nih.gov/27554239/

A potential investor should look at lots of variables such as does the Management have skin in the game, potential market size, where in the product life cycle you are joining etc. To that end, the Management Team are invested in their own company, and the CEO, Stuart Ashman left Smith and Nephew where he was Director of Sales and Marketing to join Skinbio at a significant discount to his salary because he believed in the science underpinning the Company and its potential.
Then look at a different stakeholder, Croda, who via their subsidiary Sederma, stumped up £5M of their own money to invest in a dedicated production line for the skinbiotix product because they have seen the clinical evidence for this product and realise i=t will be the only anti-ageing ingredient on the market backed by science. So when major stakeholders like the ones I have listed believe in the science why shouldn't pi's as well?

second link re interview here
https://www.youtube.com/watch?v=_0AWPHWonQM

marxist, and other new investors who may be interested in answers to the questions raised.

The question surrounding the axisbiotix patent is answered in the companies Q&A
What IP protection do you have around the product? Is it just for the specific formulation? Could a
similar product be easily developed?
• We guard our IP carefully. We have filed a patent around AxisBiotix-Ps™. We also believe
the complexity of the formulation would make it difficult to replicate.
https://axisbiotix.com/wp-content/uploads/2021/05/AxisBiotix-Ps-study-FAQs.pdf
Marx, regarding the science behind the product as opposed to your Amazon example which advocated "healthy skin" whatever that means and refers to the research carried out by other into the gut/skin axis, well Prof Cath O Neil is a published expert on the gut/skin axis and along with her team at Manchester University is responsible for a lot of the research others merely talk about. Worth watching this short interview with Cath O Neil to understand how axisbiotix came about
https://axisbiotix.com/wp-content/uploads/2021/05/AxisBiotix-Ps-study-FAQs.pdf

Good luck with you investment decision

Phat, I believe it can eventually, to which end I am surprised you do not share the same belief about Opti who finally have a sweetbiotix launch in sight and LPLDL reaching "Pharna Status", think axisbiotix when it achieves Pharmabiotix status with the higher margins it will achieve and is years away

..and I certainly can't find any stats for people with Covid who refused treatment

Belgrano, what a strange analogy? The Axis participants weren't press ganged or coerced into taking part they volunteered.

belgrano, I don't buy into the lack of a monetary inducement in this instance as we are talking about a treatment that improves that individuals life so why wouldn't you see it through? After all, the impact the condition has on an individual's quality of life is the reason behind the optimism that there will be 25000 participants signing up from day one of commercialisation and they will be paying customers not expecting payment to receive the treatment., so the question does need an answer